Dyadic International

$5.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.18 (-3.28%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell DYAI and other stocks, options, and ETFs commission-free!

About DYAI

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL. The listed name for DYAI is Dyadic International, Inc. Common Stock.

CEO
Mark A. Emalfarb
Employees
9
Headquarters
Jupiter, Florida
Founded
1979
Market Cap
153.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
164.20K
High Today
$5.54
Low Today
$5.29
Open Price
$5.49
Volume
166.24K
52 Week High
$10.98
52 Week Low
$2.51

DYAI Earnings

-$0.10
-$0.07
-$0.03
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, After Hours

You May Also Like

JSM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure